Selected research
Industry Research
Lafutidine Tablets Industry Research Report 2026
Market perspective
The global Lafutidine Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lafutidine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lafutidine Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lafutidine Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lafutidine Tablets include Yuekang Pharmaceutical Group Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Shandong Qidu Pharmaceutical Co., Ltd., Jiangsu Runbang Pharmaceutical Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Hubei Shubang Pharmaceutical Co., Ltd. and Chengdu Hengrui Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lafutidine Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lafutidine Tablets Market by Company
Yuekang Pharmaceutical Group Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd.
Shandong Qidu Pharmaceutical Co., Ltd.
Jiangsu Runbang Pharmaceutical Co., Ltd.
China Resources Double Crane Pharmaceutical Co., Ltd.
Hubei Shubang Pharmaceutical Co., Ltd.
Chengdu Hengrui Pharmaceutical Co., Ltd.
Lafutidine Tablets Segment by Type
10mg
5mg
Lafutidine Tablets Segment by Application
Hospital
Clinic
Other
Lafutidine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lafutidine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lafutidine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lafutidine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lafutidine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lafutidine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lafutidine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg
- 5mg
Applications
- Hospital
- Clinic
- Other
Companies covered
- Yuekang Pharmaceutical Group Co., Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Shandong Qidu Pharmaceutical Co., Ltd.
- Jiangsu Runbang Pharmaceutical Co., Ltd.
- China Resources Double Crane Pharmaceutical Co., Ltd.
- Hubei Shubang Pharmaceutical Co., Ltd.
- Chengdu Hengrui Pharmaceutical Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lafutidine Tablets Market Size (2021-2032)
- 2.2.2 Global Lafutidine Tablets Sales (2021-2032)
- 2.2.3 Global Lafutidine Tablets Market Average Price (2021-2032)
- 2.3 Lafutidine Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10mg
- 2.3.3 5mg
- 2.4 Lafutidine Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lafutidine Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lafutidine Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lafutidine Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Lafutidine Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Lafutidine Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lafutidine Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lafutidine Tablets, Product Type & Application
- 3.8 Global Manufacturers of Lafutidine Tablets, Established Date
- 3.9 Global Lafutidine Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yuekang Pharmaceutical Group Co., Ltd.
- 4.1.1 Yuekang Pharmaceutical Group Co., Ltd. Company Information
- 4.1.2 Yuekang Pharmaceutical Group Co., Ltd. Business Overview
- 4.1.3 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Product Portfolio
- 4.1.5 Yuekang Pharmaceutical Group Co., Ltd. Recent Developments
- 4.2 Sichuan Kelun Pharmaceutical Co., Ltd.
- 4.2.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 4.2.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Shandong Qidu Pharmaceutical Co., Ltd.
- 4.3.1 Shandong Qidu Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Shandong Qidu Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 4.3.5 Shandong Qidu Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Jiangsu Runbang Pharmaceutical Co., Ltd.
- 4.4.1 Jiangsu Runbang Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Jiangsu Runbang Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 4.4.5 Jiangsu Runbang Pharmaceutical Co., Ltd. Recent Developments
- 4.5 China Resources Double Crane Pharmaceutical Co., Ltd.
- 4.5.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
- 4.5.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 4.5.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Hubei Shubang Pharmaceutical Co., Ltd.
- 4.6.1 Hubei Shubang Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Hubei Shubang Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 4.6.5 Hubei Shubang Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Chengdu Hengrui Pharmaceutical Co., Ltd.
- 4.7.1 Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Chengdu Hengrui Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 4.7.5 Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Developments
5 Global Lafutidine Tablets Market Scenario by Region
- 5.1 Global Lafutidine Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lafutidine Tablets Sales by Region: 2021-2032
- 5.2.1 Global Lafutidine Tablets Sales by Region: 2021-2026
- 5.2.2 Global Lafutidine Tablets Sales by Region: 2027-2032
- 5.3 Global Lafutidine Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Lafutidine Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Lafutidine Tablets Revenue by Region: 2027-2032
- 5.4 North America Lafutidine Tablets Market Facts & Figures by Country
- 5.4.1 North America Lafutidine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lafutidine Tablets Sales by Country (2021-2032)
- 5.4.3 North America Lafutidine Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lafutidine Tablets Market Facts & Figures by Country
- 5.5.1 Europe Lafutidine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lafutidine Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Lafutidine Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lafutidine Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lafutidine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lafutidine Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lafutidine Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lafutidine Tablets Market Facts & Figures by Country
- 5.7.1 South America Lafutidine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lafutidine Tablets Sales by Country (2021-2032)
- 5.7.3 South America Lafutidine Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Lafutidine Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lafutidine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lafutidine Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lafutidine Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Lafutidine Tablets Sales by Type (2021-2032)
- 6.1.1 Global Lafutidine Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lafutidine Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Lafutidine Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Lafutidine Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lafutidine Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Lafutidine Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lafutidine Tablets Sales by Application (2021-2032)
- 7.1.1 Global Lafutidine Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lafutidine Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Lafutidine Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Lafutidine Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lafutidine Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Lafutidine Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lafutidine Tablets Value Chain Analysis
- 8.1.1 Lafutidine Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lafutidine Tablets Production Mode & Process
- 8.2 Lafutidine Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lafutidine Tablets Distributors
- 8.2.3 Lafutidine Tablets Customers
9 Global Lafutidine Tablets Analyzing Market Dynamics
- 9.1 Lafutidine Tablets Industry Trends
- 9.2 Lafutidine Tablets Industry Drivers
- 9.3 Lafutidine Tablets Industry Opportunities and Challenges
- 9.4 Lafutidine Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst